Literature DB >> 20682843

SK3 channel expression during pregnancy is regulated through estrogen and Sp factor-mediated transcriptional control of the KCNN3 gene.

Stephanie L Pierce1, Sarah K England.   

Abstract

Overexpression of the small-conductance calcium-activated K(+) channel 3 (SK3) in transgenic mice compromises parturition, suggesting that the SK3 channel plays a role in pregnancy. In wild-type mouse myometrium, expression of SK3 transcript and protein is significantly reduced during pregnancy, but the mechanism(s) responsible for this attenuation of channel expression is unknown. The promoter region of the SK3-encoding mouse KCNN3 gene contains two binding sites for specificity protein (Sp) transcription factors, two of which are expressed in the uterus: Sp1, which enhances gene transcription in response to estrogen; and Sp3, which competes for the same binding motif as Sp1 and can repress gene expression. We investigated the hypothesis that Sp1 and Sp3 regulate SK3 channel expression during pregnancy. In mouse myometrium, Sp1 expression was reduced during late gestation, whereas Sp3 expression levels were constant throughout pregnancy. Using a reporter system, we found that Sp1 overexpression resulted in a significant increase in SK3 promoter activation and that Sp3 cotransfection reduced promoter activation to basal levels. These findings indicate that Sp3 outcompetes Sp1 to decrease SK3 transcription. To determine whether high levels of estrogen in vivo can affect the regulation of SK3 protein levels by Sp factors, ovariectomized mice were implanted with a 17β-estradiol or placebo pellet for 3 wk; estrogen-treated mice had reduced uterine SK3 protein expression compared with placebo-treated counterparts. In human myometrial cells overexpressing Sp1, estrogen treatment stimulated expression of the SK3 transcript. Overall, our findings indicate that Sp1 and Sp3 compete to regulate SK3 channel expression during pregnancy in response to stimulation by estrogen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682843      PMCID: PMC2957868          DOI: 10.1152/ajpendo.00063.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  32 in total

1.  Complexity of translationally controlled transcription factor Sp3 isoform expression.

Authors:  Alexandra Sapetschnig; Franziska Koch; Grigore Rischitor; Trientje Mennenga; Guntram Suske
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

2.  An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.

Authors:  J Dennig; M Beato; G Suske
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

3.  Gestational changes in the uterine expression of an inwardly rectifying K+ channel, ROMK.

Authors:  D W Lundgren; J J Moore; S M Chang; P L Collins; A S Chang
Journal:  Proc Soc Exp Biol Med       Date:  1997-10

Review 4.  What knockout mice can tell us about parturition.

Authors:  T Kimura; K Ogita; C Kusui; K Ohashi; C Azuma; Y Murata
Journal:  Rev Reprod       Date:  1999-05

5.  Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.

Authors:  M F Severino; M J Murray; D D Brandon; G M Clinton; K A Burry; M J Novy
Journal:  Mol Hum Reprod       Date:  1996-11       Impact factor: 4.025

6.  Estrogen mediates the protective effects of pregnancy and chorionic gonadotropin in a mouse model of vascular injury.

Authors:  L Zhang; M C Fishman; P L Huang
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

7.  Contribution of coupling between human myometrial beta2-adrenoreceptor and the BK(Ca) channel to uterine quiescence.

Authors:  Boonsri Chanrachakul; Fiona Broughton Pipkin; Raheela N Khan
Journal:  Am J Physiol Cell Physiol       Date:  2004-08-25       Impact factor: 4.249

8.  Properties of large-conductance K+ channels in human myometrium during pregnancy and labour.

Authors:  R N Khan; S K Smith; J J Morrison; M L Ashford
Journal:  Proc Biol Sci       Date:  1993-01-22       Impact factor: 5.349

9.  SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels.

Authors:  Aaron Kolski-Andreaco; Hiroaki Tomita; Vikram G Shakkottai; George A Gutman; Michael D Cahalan; J Jay Gargus; K George Chandy
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

10.  GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K(+) channel gene in cardiac myocytes and PC12 cells.

Authors:  Ying Jia; Koichi Takimoto
Journal:  Cardiovasc Res       Date:  2003-11-01       Impact factor: 10.787

View more
  15 in total

1.  Gestational hypoxia increases reactive oxygen species and inhibits steroid hormone-mediated upregulation of Ca(2+)-activated K(+) channel function in uterine arteries.

Authors:  Ronghui Zhu; Xiaohui Huang; Xiang-Qun Hu; DaLiao Xiao; Lubo Zhang
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

2.  Single-nucleotide polymorphisms in the KCNN3 gene associate with preterm birth.

Authors:  Lori J Day; Kendra L Schaa; Kelli K Ryckman; Meg Cooper; John M Dagle; Chin-To Fong; Hyagriv N Simhan; David C Merrill; Mary L Marazita; Jeffrey C Murray; Sarah K England
Journal:  Reprod Sci       Date:  2011-01-25       Impact factor: 3.060

3.  Polymorphisms in the fetal progesterone receptor and a calcium-activated potassium channel isoform are associated with preterm birth in an Argentinian population.

Authors:  P C Mann; M E Cooper; K K Ryckman; B Comas; J Gili; S Crumley; E N A Bream; H M Byers; T Piester; A Schaefer; P J Christine; A Lawrence; K L Schaa; K J P Kelsey; S K Berends; A M Momany; E Gadow; V Cosentino; E E Castilla; J López Camelo; C Saleme; L J Day; S K England; M L Marazita; J M Dagle; J C Murray
Journal:  J Perinatol       Date:  2012-09-27       Impact factor: 2.521

4.  Isolation and characterization of the 5´-upstream region of the human voltage-gated Ca(2+) channel α 2δ-1 auxiliary subunit gene: promoter analysis and regulation by transcription factor Sp1.

Authors:  Elizabeth Martínez-Hernández; Ricardo González-Ramírez; Alejandro Sandoval; Bulmaro Cisneros; Rodolfo Delgado-Lezama; Ricardo Felix
Journal:  Pflugers Arch       Date:  2012-12-15       Impact factor: 3.657

5.  Chronic hypoxia inhibits pregnancy-induced upregulation of SKCa channel expression and function in uterine arteries.

Authors:  Ronghui Zhu; Xiang-Qun Hu; Daliao Xiao; Shumei Yang; Sean M Wilson; Lawrence D Longo; Lubo Zhang
Journal:  Hypertension       Date:  2013-05-28       Impact factor: 10.190

6.  Intragenic Transcriptional cis-Antagonism Across SLC6A3.

Authors:  Ying Zhao; Jinlong Yu; Juan Zhao; Xiaowu Chen; Nian Xiong; Tao Wang; Hong Qing; Zhicheng Lin
Journal:  Mol Neurobiol       Date:  2018-09-27       Impact factor: 5.590

7.  Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Steven J Korzeniewski; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-07-31       Impact factor: 3.886

Review 8.  Transcriptional control of parturition: insights from gene regulation studies in the myometrium.

Authors:  Nawrah Khader; Virlana M Shchuka; Oksana Shynlova; Jennifer A Mitchell
Journal:  Mol Hum Reprod       Date:  2021-05-08       Impact factor: 4.025

9.  Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells.

Authors:  Jeong-Ha Lee; Jun-Won Park; Jun Kyu Byun; Hark Kyun Kim; Pan Dong Ryu; So Yeong Lee; Dae-Yong Kim
Journal:  Oncotarget       Date:  2015-04-10

10.  Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4.

Authors:  Jonathan Berrout; Mykola Mamenko; Oleg L Zaika; Lihe Chen; Wenzheng Zhang; Oleh Pochynyuk; Roger G O'Neil
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.